Cargando…
Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease
AIM: The renoprotective effect of sodium-glucose cotransporter 2 inhibitors is thought to be due, at least in part, to a decrease in blood pressure. The aim of this study was to determine the renal effects of these inhibitors in low blood pressure patients and the dependence of such effect on blood...
Autores principales: | Kobayashi, Kazuo, Toyoda, Masao, Kaneyama, Noriko, Hatori, Nobuo, Furuki, Takayuki, Sakai, Hiroyuki, Takihata, Masahiro, Umezono, Tomoya, Ito, Shun, Suzuki, Daisuke, Takeda, Hiroshi, Kanamori, Akira, Degawa, Hisakazu, Yamamoto, Hareaki, Machimura, Hideo, Mokubo, Atsuko, Chin, Keiichi, Obana, Mitsuo, Hishiki, Toshimasa, Aoyama, Kouta, Nakajima, Shinichi, Umezawa, Shinichi, Shimura, Hidetoshi, Aoyama, Togo, Miyakawa, Masaaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875192/ https://www.ncbi.nlm.nih.gov/pubmed/31781668 http://dx.doi.org/10.1155/2019/9415313 |
Ejemplares similares
-
Blood pressure after treatment with sodium–glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score‐matched models
por: Kobayashi, Kazuo, et al.
Publicado: (2020) -
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists
por: Kobayashi, Kazuo, et al.
Publicado: (2023) -
Polypharmacy influences the renal composite outcome in patients treated with sodium‐glucose cotransporter 2 inhibitors
por: Kobayashi, Kazuo, et al.
Publicado: (2022) -
Sodium–glucose cotransporter 2 inhibitor‐induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score‐matched model analysis in Japan
por: Kobayashi, Kazuo, et al.
Publicado: (2021) -
Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists
por: Kobayashi, Kazuo, et al.
Publicado: (2022)